Icon Wealth Partners’s Loxo Oncology, Inc LOXO Stock Holding History

Icon Wealth Partners’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-215	Closed	-$37K	–	815
2018 Q2	$37K	Buy	+215	New	+$32.3K	0.02%	452

Other funds holding LOXO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Icon Wealth Partners's LOXO Position: Q3 2018 in Review

Icon Wealth Partners sold out of Loxo Oncology, Inc (LOXO) in Q3 2018, closing a stake of 215 shares — an estimated $37K sold.

Icon Wealth Partners first reported a position in LOXO in Q2 2018 and held it in 1 quarter. The position peaked at $37K in Q2 2018. 228 funds tracked by Wall St. Rank hold LOXO as of Q3 2018.

Icon Wealth Partners reported no remaining Loxo Oncology, Inc position as of Q3 2018 after selling out during the quarter.
Icon Wealth Partners sold 215 Loxo Oncology, Inc shares in Q3 2018, an estimated $37K.
Icon Wealth Partners first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 1 quarter.
Icon Wealth Partners's Loxo Oncology, Inc position peaked at $37K in Q2 2018.
228 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2018.

Based on Icon Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.